Novartis (NYSE: NVS) reported Q4 EPS of $1.53, $0.12 worse than the analyst estimate of $1.65. Revenue for the quarter came in at $11.42 billion versus the consensus estimate of $11.9 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.